IRESSA gefitinib 250 mg tablet blister pack

AstraZeneca Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 0202c2d590a08703
Product Name: IRESSA gefitinib 250 mg tablet blister pack
Artg Id: 90010
Artg Name: IRESSA gefitinib 250 mg tablet blister pack
Sponsor: AstraZeneca Pty Ltd
Company Detail Path: /organization/astrazeneca-pty-ltd
Artg Date: 2003-04-28
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/190ab9d3b11557244f8bf1aa4657dd07.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/868d901cd2d30395fe4c56b2fe97608d.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

0202c2d590a08703

Type

Standard